Halloran Town Hall: Achieving Better Clinical Trial Outcomes by Strategically Targeting Underserved Patient Populations

Companies sponsoring a clinical trial often discuss Diversity, Equity, and Inclusion (DE&I) efforts to achieve better outcomes for their patients and their trial, but those discussions don’t often translate into the design. As an industry, it’s time to put our money where our mouth is and implement DE&I efforts into trial designs. Including underserved populations will only provide better outcomes for organizations but that’s not to say there won’t be roadblocks and speedbumps along the way.

In our upcoming Town Hall, our panel will discuss actions for organizations to take to achieve the best clinical data outcomes while also implementing the best DE&I strategies. We’ll be joined by:

Rashida Challenger, Senior Consultant, Clinical Operations, Halloran Consulting Group
Michele Rhee, VP, Patient Affairs & Advocacy, X4 Pharmaceuticals
Jocelyn M. Ashford, Senior Director, Global Patient Advocacy, Eidos Therapeutic
Ryan Pack, Global Head of Diversity in Clinical Trials Business Unit & Diversity in Clinical Trials Foundation, Science37
Discussion points will include:

Strategies to target underserved patient populations
New ways to engage patient advocacy groups
Designing more meaningful trials that are less burdensome to patients
Issues and that organizations may face during trial design and implementation and how to fix/avoid them
We’re looking forward to an interactive and informative session with the industry’s leading experts!

Upon registration you will receive a calendar invite with Zoom info.

Please feel free to distribute this event and any questions, contact speakerseries@hallorancg.com.